First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms1GenePHIT is a clinical trial to evaluate the safety and efficacy of the one-time administration of AB-1002 and will include the largest number.
/PRNewswire/ Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people s health and the quality of patients .
/CNW/ The DDC Group, the worldwide network of business process outsourcing (BPO) companies, is excited to announce further expansion in the Balkan region.